News

Sanofi Pasteur, the vaccines division of Sanofi-Aventis Group, has received marketing authorization from the Australian Therapeutic Goods Administration for Emerflu, the company’s pandemic influenza vaccine for human use.

Dyax, a US-based clinical stage biopharmaceutical company, has announced that it is eliminating 60 positions from various departments within the company to focus its resources on the commercialization

By entering the second phase, Merck gains access to a new multi-million member library of small molecule drug candidates. In addition, this development triggers the payment of an

Mr Newton most recently served in various executive officer roles at Synenco Energy, from 2004 to 2008, including as president and CEO; president and COO; and executive vice

The MRSAid photodisinfection system is designed to reduce Methicillin-resistant Staphylococcus aureus (MRSA) colonization of the anterior nasal passages, the company said. Carolyn Cross, chairman and CEO of Ondine,

ChemImage will be partnering with Next Breath to compare optical microscopy to Raman Chemical Imaging, specifically ChemImage’s Falcon II wide-field Raman chemical imaging system. The Falcon II enables

The Mobility trial is designed to study 150 patients at up to 50 centers in the US. The primary endpoint is a composite measure of major adverse events

Arca biopharma has reported data from the pivotal Phase III Best trial of Gencaro in patients with advanced chronic heart failure. The trial results demonstrated that, in a

Mr Stefano is senior vice president of GlaxoSmithKline’s payor markets division and has spent 23 years leading GlaxoSmithKline’s managed markets division. Mr Stefano has held numerous positions at